This report updates progress toward the elimination of rubella and congenital rubella syndrome (CRS) from 2012 to 2022. During this period, the percentage of World Health Organization (WHO) countries including rubella-containing vaccines (RCVs) in their immunization schedules increased from 68% to 90%, and the percentage of infants vaccinated against rubella increased from 40% to 68%. Global rubella incidence declined by 81% from 2013 to 2021. Enhanced surveillance for CRS led to increased detection of cases. By 2022, rubella elimination had been verified in 98 countries (51% of all countries), with no reestablishment of endemic transmission in any verified country. Despite significant progress, approximately 25 million infants still lack access to RCV annually, primarily in low-income and conflict-affected areas. The report emphasizes the need for universal introduction of RCV to accelerate global rubella elimination.This report updates progress toward the elimination of rubella and congenital rubella syndrome (CRS) from 2012 to 2022. During this period, the percentage of World Health Organization (WHO) countries including rubella-containing vaccines (RCVs) in their immunization schedules increased from 68% to 90%, and the percentage of infants vaccinated against rubella increased from 40% to 68%. Global rubella incidence declined by 81% from 2013 to 2021. Enhanced surveillance for CRS led to increased detection of cases. By 2022, rubella elimination had been verified in 98 countries (51% of all countries), with no reestablishment of endemic transmission in any verified country. Despite significant progress, approximately 25 million infants still lack access to RCV annually, primarily in low-income and conflict-affected areas. The report emphasizes the need for universal introduction of RCV to accelerate global rubella elimination.